Are Plants Used as a Combating Strategy against Tuberculosis in the Mpumalanga Province, South Africa?

被引:1
作者
Sagbo, Idowu Jonas [1 ]
Hussein, Ahmed A. [1 ]
机构
[1] Cape Peninsula Univ Technol, Dept Chem, Symphony Rd,Bellville Campus, ZA-7535 Bellville, South Africa
来源
APPLIED SCIENCES-BASEL | 2023年 / 13卷 / 08期
关键词
antituberculosis drugs; side effects; medicinal plants; tuberculosis; Mpumalanga; IN-VITRO INHIBITION; MYCOBACTERIUM-TUBERCULOSIS; MEDICINAL-PLANTS; ANTITUBERCULAR ACTIVITY; ANTIMYCOBACTERIAL ACTIVITY; TREAT TUBERCULOSIS; DRUG-RESISTANT; PROTEIN;
D O I
10.3390/app13085008
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The burden of tuberculosis (TB) disease is a global health challenge accounting for thousands of deaths. TB is unevenly distributed in South Africa, with some provinces having more than 70% of the TB burden. In Mpumalanga Province, TB is ranked as the sixth leading cause of death. Antituberculosis agents are usually costly, with numerous unwanted side effects. This has prompted the major use of herbs which have an imperative biological role against tuberculosis and are easily accessible. A comprehensive review of plants used as a combating strategy against tuberculosis in Mpumalanga Province was conducted. An in-depth literature search was performed using scientific databases, theses, dissertations and ethnobotanical books. Twenty-four (24) plant species were reported by the people of Mpumalanga for the treatment of tuberculosis. Fifteen (15) plant species have been investigated for antituberculosis activities, and seven antimycobacterial compounds were successfully isolated. This review validates the use of plants against tuberculosis in Mpumalanga Province and, thus, identified species that may be explored for further scientific studies.
引用
收藏
页数:18
相关论文
共 85 条
  • [1] Adaikkappan P., 2012, J ACAD IND RES, V1, P53
  • [2] Helichrysum Genus and Compound Activities in the Management of Diabetes Mellitus
    Akinfenwa, Akeem O.
    Sagbo, Idowu J.
    Makhaba, Masixole
    Mabusela, Wilfred T.
    Hussein, Ahmed A.
    [J]. PLANTS-BASEL, 2022, 11 (10):
  • [3] Ament PW, 2002, AM FAM PHYSICIAN, V65, P663
  • [4] [Anonymous], 2022, Tuberculosis
  • [5] [Anonymous], 1994, TB GLOB EM
  • [6] Anti-Mycobacterium tuberculosis activity of essential oil and 6,7-dehydroroyleanone isolated from leaves of Tetradenia riparia (Hochst.) Codd (Lamiaceae)
    Baldin, Vanessa Pietrowski
    de Lima Scodro, Regiane Bertin
    Lopes-Ortiz, Mariana Aparecida
    de Almeida, Aryadne Larissa
    Gazim, Zilda Cristiani
    Ferarrese, Leticia
    Faioes, Viviane dos Santos
    Torres-Santos, Eduardo Caio
    Agostinho Pires, Claudia Terencio
    Caleffi-Ferracioli, Katiany Rizzieri
    Dias Siqueira, Vera Lucia
    Garcia Cortez, Diogenes Aparicio
    Cardoso, Rosilene Fressatti
    [J]. PHYTOMEDICINE, 2018, 47 : 34 - 39
  • [7] Berning S.E., 1998, ANTIMICROB AGENTS CH
  • [8] Drug treatment for tuberculosis during pregnancy - Safety considerations
    Bothamley, G
    [J]. DRUG SAFETY, 2001, 24 (07) : 553 - 565
  • [9] EFFECT OF RIFAMYCIN ON PROTEIN SYNTHESIS
    CALVORI, C
    FRONTALI, L
    LEONI, L
    TECCE, G
    [J]. NATURE, 1965, 207 (4995) : 417 - &
  • [10] Centre for Diseases Control and Prevention (CDC), TRANSM PATH TUB